Testing effectiveness (Phase 2)Ended earlyNCT04267120
What this trial is testing
Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)
Who this might be right for
Renal Cell Carcinoma
Washington University School of Medicine 11